PPARγ and SREBP1 expression by Western blotting in p1 and p21 adipocytes at baseline and with rosiglitazone treatment. SGA maintained higher expression of PPARγ than Controls at baseline and stimulated states. (A) p1 Control and SGA adipocytes responded to rosiglitazone at both doses. (B) p21 SGA adipocytes responded only to high dose rosiglitazone. *p < 0.05 compared to untreated cells within the same group. cp < 0.05 compared to Controls treated with the same dose of rosiglitazone.